SPONSOR
Dartmouth-Hitchcock Medical Center
Total Trials
11
Recruiting
11
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: GlioblastomaGlial TumorBrain MetastasesMeningiomaSchwannomaPituitary TumorTriple Negative Breast CancerResidual DiseaseTobacco DependencePediatric Mental Health Services
Dartmouth-Hitchcock Medical Center is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Glioblastoma, Glial Tumor, Brain Metastases, Meningioma.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dartmouth-Hitchcock Medical Center
How many clinical trials has Dartmouth-Hitchcock Medical Center sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Dartmouth-Hitchcock Medical Center, of which 11 are actively recruiting participants. These trials cover conditions including Glioblastoma, Glial Tumor, Brain Metastases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dartmouth-Hitchcock Medical Center research focus on?
Dartmouth-Hitchcock Medical Center clinical trials span Glioblastoma, Glial Tumor, Brain Metastases, Meningioma, Schwannoma, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dartmouth-Hitchcock Medical Center clinical trial?
To participate in a Dartmouth-Hitchcock Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dartmouth-Hitchcock Medical Center trials with current recruitment status updated daily.
Clinical Trials by Dartmouth-Hitchcock Medical Center
NCT05139277
Recruiting
Evaluation of the CONVIVO System
Glioblastoma
NCT06134375 Phase 1, Phase 2
Recruiting
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Triple Negative Breast Cancer
NCT06543407
Recruiting
Harm Reduction for Smokers With Mental Illness
Tobacco Dependence
NCT06838689
Recruiting
Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research
Pediatric Mental Health Services
NCT05933395 Phase 2
Recruiting
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Advanced Breast Cancer
NCT05529264
Recruiting
Human Intracranial Electrophysiology
Epilepsy
NCT06522568
Recruiting
Testing a Mammography Decision Intervention in a Rural Setting
Breast Cancer
NCT07201376
Recruiting
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
Non-Melanoma Skin Cancer (NMSC)
NCT07706556
Recruiting
Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors
Breast Cancer
NCT06102486
Recruiting
MCI Speech in Noise
Mild Cognitive Impairment
NCT07071038 Phase 2
Recruiting
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology